Hyperglycemia associated with Chagas disease

Keywords: Diabetes mellitus, Trypanosoma cruzi, detection, obesity

Abstract

Chagas disease and type 2 diabetes mellitus are the two main causes of Years Lived with Disability. The consequences and possible interaction between both illnesses have been scarcely studied. A population study of blood donors from the Centro Estatal de Transfusión Sanguinea (CETS) was carried out with a reagent related to the Chagas test. Detection was carried out with an enzyme-linked immunosorbent assay (ELISA) of anti- Trypanosoma cruzi antibodies and also, an HbA1C test was performed with 4 mL of whole blood. Descriptive statistics were used to analyze quantitative and qualitative data. The Chi-square test was applied to determine the existence of an association between hyperglycemia and Chagas disease. A total of 4,952 participants were screened. All of the participants (100%) were from Hidalgo State and did not have a chagoma as evidence of having been bitten or denied contact with a “kissing bug”. Of the total, 26 reacted to the first screening test to detect anti-Trypanosoma cruzi antibodies; of these, five were confirmed as positive on the second screening test. The seroprevalence of T. cruzi was 0.01%. The results do not show a clear association but the frequency of hyperglycemia in population with Chagas coincides with that reported by other authors. Considering the scarce clinical–epidemiological evidence between Chagas disease, obesity, and hyperglycemia, long-term follow up of both morbidities is an area of opportunity for clinical and epidemiological study of T. cruzi reactivity.

Downloads

Download data is not yet available.

References

American Diabetes Association. (2021). Understanding A1C A1C does it all. Recuperado el 11 de octubre de 2021, de https://www.diabetes.org/a1c.

Barraza Lloréns, M., Guajardo-Barrón, V Hernández Viveros, C., Picó Guzmán, F., Crable, E., García González, R., Mora Alba, F., … Urtiz Madrigal, A. (2015). Carga económica de la diabetes mellitus en México, 2013. Funsalud. Recuperado de http://www.funsalud.org.mx.

Bechah, Y., Paddock, C. D., Capo, C., Mege, J. L., & Raoult, D. (2010). Adipose tissue serves as a reservoir for recrudescent Rickettsia prowazekii infection in a mouse model. PLoS ONE, 5(1), 1–7. https://doi.org/10.1371/journal.pone.0008547.

Carabarin-Lima, A., González-Vázquez, M. C., Rodríguez-Morales, O., Baylón-Pacheco, L., Rosales-Encina, J. L., Reyes-López, P. A., & Arce-Fonseca, M. (2013). Chagas disease (American trypanosomiasis) in Mexico: An update. Acta Tropica, 127(2), 126–135. https://doi.org/10.1016/j.actatropica.2013.04.007.

Chagas, C. (2009). Nouvelle espèce de trypanosomiase humaine. Bulletin de la Societe de Pathologie Exotique, 102(5), 352–355.

Combs, T. P., Nagajyothi, Mukherjee, S., De Almeida, C. J. G., Jelicks, L. A., Schubert, W., … Scherer, P. E. (2005). The adipocyte as an important target cell for Trypanosoma cruzi infection. Journal of Biological Chemistry, 280(25), 24085–24094. https://doi.org/10.1074/jbc.M412802200.

Desruisseaux, M. S., Nagajyothi, Trujillo, M. E., Tanowitz, H. B., & Scherer, P. E. (2007). Adipocyte, adipose tissue, and infectious disease. Infection and Immunity, 75(3), 1066–1078. https://doi.org/10.1128/IAI.01455-06.

Dos Santos, V. M., da Cunha, S. F., Teixeira, V. P., Monteiro, J. P., dos Santos, J. A., dos Santos, T. A., … da Cunha, D. F. (1999). Freqüência de diabetes mellitus e hiperglicemia em mulheres chagásicas e nao-chagásicas. Revista da Sociedade Brasileira de Medicina Tropical, 32(5), 489–496. https://doi.org/10.1590/S0037-86821999000500004.

Dumonteil, E. (1999). Update on Chagas’ disease in Mexico. Salud Publica de Mexico, 41(4), 322–327. https://doi.org/10.1590/S0036-36341999000400010.

Geraix, J., Ardisson, L. P., Marcondes-Machado, J., & Pereira, P. C. M. (2007). Clinical and nutritional profile of individuals with chagas disease. Brazilian Journal of Infectious Diseases, 11(4), 411–414. https://doi.org/10.1590/S1413-86702007000400008.

Hidron, A. I., Gilman, R. H., Justiniano, J., Blackstock, A. J., LaFuente, C., Selum, W., … Bern, C. (2010). Chagas cardiomyopathy in the context of the chronic disease transition. PLoS Neglected Tropical Diseases, 4(5). https://doi.org/10.1371/journal.pntd.0000688.

Instituto Nacional de Salud Pública. (2018). ENSANUT. Encuesta Nacional de Salud y Nutrición. Hidalgo. Recuperado el 5 de noviembre de 2021, de https://ensanut.insp.mx/encuestas/ensanut2018/doctos/informes/Resultado_Entidad_Hidalgo.pdf..

Lozano, A. R., Gómez-Dantés, H., Pelcastre, V. B. E., Ruelas, G. M. G., Montañez, J. C., Campuzano, J. C., … González, V. J. J. (2014). Carga de la enfermedad en México 1990-2010. Nuevos resultados y desafíos (Primera). México: Instituto Nacional de Salud Pública / Secretaría de Salud..

Monteón, V. M., Reyes-López, P. A., Sosa-Palacio, A., León-Tello, G., Martínez-Murguía, J., & Sosa-Jurado, F. (2005). Distribución heterogénea de la prevalencia de anticuerpos contra Trypanosoma cruzi en donadores de sangre en Puebla, México. Salud Publica de Mexico, 47(2), 116–125. https://doi.org/10.1590/S0036-36342005000200005.

Nagajyothi, F., Desruisseaux, M. S., Jelicks, L. a, Machado, F. S., Chua, S., Scherer, P. E., & Tanowitz, H. B. (2009). Perspectives on adipose tissue, chagas disease and implications for the metabolic syndrome. Interdisciplinary perspectives on infectious diseases, 2009, 824324. https://doi.org/10.1155/2009/824324.

Nagajyothi, F., Machado, F. S., Burleigh, B. A., Jelicks, L. A., Scherer, P. E., Mukherjee, S., … Tanowitz, H. B. (2012). Mechanisms of Trypanosoma cruzi persistence in Chagas disease. Cellular Microbiology, 14(5), 634–643. https://doi.org/10.1111/j.1462-5822.2012.01764.x.

Navarro, E. C., Miziara De Abreu, M., Tavares, F. C., Corrente, J. E., Maria De Arruda, C., Câmara, P., & Pereira, M. (2013). Indeterminate Form of Chagas’ Disease and Metabolic Syndrome: A Dangerous Combination. American Journal of M edicine and M edical Sciences, 3(4), 68–73. https://doi.org/10.5923/j.ajmms.20130304.03.

Neyrolles, O., Hernández-Pando, R., Pietri-Rouxel, F., Fornès, P., Tailleux, L., Payán, J. A. B., … Gicquel, B. (2006). Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS ONE, 1(1). https://doi.org/10.1371/journal.pone.0000043.

Ramsey, J., Ordoñez, R., Tello-López, A., Pohls, J. L., Sanchez, V., & Peterson, a T. (2003). Actualidades sobre la epidemiología de la enfermedad de Chagas en México. Researchgate, (May 2017), 85–103.

Resende, B. A. M., Beleigoli, A. M. R., Ribeiro, A. L. P., Duncan, B., Schmidt, M. I., Mill, J. G., … Diniz, M. D. F. H. S. (2021). Chagas disease is not associated with diabetes, metabolic syndrome, insulin resistance and beta cell dysfunction at baseline of Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Parasitology International, 85(August). https://doi.org/10.1016/j.parint.2021.102440.

Saumell, C. R., & Soriano-arandes, A. (2015). Documento de consenso sobre el abordaje de la enfermedad de Chagas en atención primaria de salud de áreas no endémicas. Atención Primaria, 47(5), 308–317.

Schäffler, A., Müller-Ladner, U., Schölmerich, J., & Büchler, C. (2006). Role of adipose tissue as an inflammatory organ in human diseases. Endocrine Reviews, 27(5), 449–467. https://doi.org/10.1210/er.2005-0022.

Secretaria de Salud. (2012). NORMA Oficial Mexicana NOM-253-SSA1-2012, Para la disposición de sangre humana y sus componentes con fines terapéuticos, 2012.

Velasco- Castrejon, O., Valdespino, J. L., Tapia-Conyer, R., Salvatierra, B., Guzmán- Bracho, C., Magos, C., … Sepulveda, J. (1992). Seroepidemiología de la enfermedad de Chagas en México. Salud Pública de México, 34(2), 186–196. https://doi.org/10.1590/S0102-311X200200060002400028.

World Health Organization. (2021). Chagas disease (also known as American trypanosomiasis). Recuperado el 11 de octubre de 2021, de https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis).

Published
2022-01-05